Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study
Titel:
Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study
Auteur:
Pavel, M.E. Baudin, E. Öberg, K.E. Hainsworth, J.D. Voi, M. Rouyrre, N. Peeters, M. Gross, D.J. Yao, J.C.